作者piglauhk (我要当阳光型男!!)
看板Patent
标题Re: [问题] MPEP 2100 译文
时间Tue Sep 1 16:00:56 2009
不好意思最近占了很多版面 敬请原谅
听了C大跟V兄的建议. 开始对MPEP 2100下手.
前菜是索引 分三天贴出
请各位先辈以严格的标准来审视 有请多多指教批评
^)^
2100 Patentability
可专利性
2126 Availability of a Document as a "Patent" for Purposes of Rejection Under
35 U.S.C. 102 (a), (b), and (d) [R-5]
将"专利文件"用作 35 U.S.C. 102 (a), (b), and (d)核驳的可行性
2126.01 Date of Availability of a Patent as a Reference [R-3]
专利文件可被应用为引证之日期
2126.02 Scope of Reference's Disclosure Which Can Be Used to Reject Claims
When the Reference Is a "Patent" but Not a "Publication"
当引证资料系一"专利文件" 而非一 "刊物"时,
该"专利文件"中可被用来核驳专利申请专利范围(claim)之范围
2127 Domestic and Foreign Patent Applications as Prior Art [R-6]
以本国及外国专利申请文件为先前技术
2128 "Printed Publications" as Prior Art [R-5]
利用"印刷刊物"为先前技术
2128.01 Level of Public Accessibility Required [R-3]
对大众是否可取得之规定的程度要求
2128.02 Date Publication Is Available as a Reference
附有日期的刊物可被当作为一引证
2129 Admissions as Prior Art [R-6]
以口供作为先前技艺
2131 Anticipation - Application of 35 U.S.C. 102 (a), (b), and (e)
合理预期 - 根据 35 U.S.C. 102 (a), (b) 及 (e) 所为之申请案
2131.01 Multiple Reference 35 U.S.C. 102 Rejections
同时引用多个引证以为35 U.S.C. 102之核驳
2131.02 Genus-Species Situations [R-6]
基因-物种之情况
2131.03 Anticipation of Ranges [R-6]
范围的合理预期
2131.04 Secondary Considerations
次要考量因素(二次要因)
2131.05 Nonanalogous or Disparaging Prior Art [R-5]
不同技术领域 或 对申请案具有负面影响(?)的先前技术
2132 35 U.S.C. 102(a)
2132.01 Publications as 35 U.S.C. 102 (a) Prior Art
35 U.S.C. 102(a)中所记载之先前技艺
2133 35 U.S.C. 102(b)
2133.01 Rejections of Continuation-In-Part (CIP) Applications
部份延续申请案之核驳
2133.02 Rejections Based on Publications and Patents
根据刊物及专利而为之核驳
2133.03 Rejections Based on "Public Use" or "On Sale" [R-5]
根据"己为公开使用"或"己为销售"而为之核驳
2133.03(a) "Public Use" [R-5]
"己为公开使用"
2133.03(b) "On Sale" [R-5]
"己为销售"
2133.03(c) The "Invention" [R-5]
"发明"一词
2133.03(d) "In This Country"
"在这国家"(美国)一词
2133.03(e) Permitted Activity; Experimental Use [R-3]
已被准许的活动;实验性使用
2133.03(e)(1) Commercial Exploitation
商业上的开发使用
2133.03(e)(2) Intent
意图
2133.03(e)(3) "Completeness" of the Invention [R-3]
发明的"完整性"
2133.03(e)(4) Factors Indicative of an Experimental Purpose [R-5]
用於判断是否实验上应用的要件之组成
2133.03(e)(5) Experimentation and Degree of Supervision and Control [R-5]
试验及其监督和控制之程度
2133.03(e)(6) Permitted Experimental Activity and Testing [R-3]
被核许的实验活动及测试
2133.03(e)(7) Activity of an Independent Third Party Inventor
独立第三人发明人的行为
2134 35 U.S.C. 102(c)
2135 35 U.S.C. 102(d)
2135.01 The Four Requirements of 35 U.S.C. 102(d)
35 U.S.C. 102(d)的四个规范
2136 35 U.S.C. 102(e) [R-3]
2136.01 Status of U.S. Application as a Reference [R-3]
以美国申请案 来作为引证之条件
2136.02 Content of the Prior Art Available Against the Claims [R-3]
先前技术可用以对抗申请专利范围的内容
2136.03 Critical Reference Date [R-6]
引证监定日期
2136.04 Different Inventive Entity; Meaning of "By Another"
不同的申请个体;"被他人"一词的意义
2136.05 Overcoming a Rejection Under 35 U.S.C. 102(e)
克服35 U.S.C. 102(e)核驳(的条件)
2137 35 U.S.C. 102(f)
2137.01 Inventorship [R-3]
适格发明人
2137.02 Applicability of 35 U.S.C. 103(c) [R-3]
35 U.S.C. 103(c)的可申请性
2138 35 U.S.C. 102(g) [R-3]
2138.01 Interference Practice [R-3]
实施冲突
2138.02 "The Invention Was Made in This Country"
"此发明系於本国完成"一词
2138.03 "By Another Who Has Not Abandoned, Suppressed, or Concealed It"
"被 没有被抛弃、禁止阪表或隐蔽的他人"
2138.04 "Conception" [R-5]
"概念"一词
2138.05 "Reduction to Practice" [R-5]
"付诸实现"一词
2138.06 "Reasonable diligence"
"付出合理的努力"一词
以上
--
※ 发信站: 批踢踢实业坊(ptt.cc)
◆ From: 140.122.46.150
※ 编辑: piglauhk 来自: 211.21.159.67 (07/13 16:21)